review of information retrieval – first experiences in germany with manufacturer dossiers on new...

24
9th HTAi Annual Meeting BILBAO 26 June 2012 Dr. Siw Waffenschmidt Information Management Unit, IQWiG Review of information retrieval – first experiences in Germany with manufacturer dossiers on new drugs

Upload: htai-bilbao-2012

Post on 07-May-2015

272 views

Category:

Health & Medicine


1 download

DESCRIPTION

Review of information retrieval – first experiences in Germany with manufacturer dossiers on new drugs

TRANSCRIPT

Page 1: Review of information retrieval – first experiences in Germany with manufacturer dossiers on new drugs

9th HTAi Annual Meeting BILBAO26 June 2012Dr. Siw Waffenschmidt

Information Management Unit, IQWiG

Review of information retrieval – first experiences in Germany with manufacturer dossiers on new drugs

Page 2: Review of information retrieval – first experiences in Germany with manufacturer dossiers on new drugs

Content

1) Introduction to the early benefit assessment of new drugs

2) Requirements for information retrieval in the dossier template

3) Review of information retrieval by IQWiG

4) Examples

Informationsbeschaffung in Dossiers 2

Page 3: Review of information retrieval – first experiences in Germany with manufacturer dossiers on new drugs

Submission of a dossier by the manufacturer

Assessment (by IQWiG)

Decision on added benefit by the Federal

Joint Committee

Added benefit?

Permissible for reference price?

no

Reference price

Price at no added cost versus comparator treatment

no

Price negotiations SHI and

manufacturer

Agreement?Discount on sales price

Decision by arbitration body

On request of SHI or manufacturer: health economic evaluation

yes

yes

Month 6

Month 12

Market entry

Month 3

Month 15

no

yes

Price set by manufacturer

Drug assessment according to AMNOG

3

Page 4: Review of information retrieval – first experiences in Germany with manufacturer dossiers on new drugs

Content

1) Introduction to the early benefit assessment of new drugs

2) Requirements for information retrieval in the dossier template

3) Review of information retrieval by IQWiG

4) Examples

Informationsbeschaffung in Dossiers 4

Page 5: Review of information retrieval – first experiences in Germany with manufacturer dossiers on new drugs

Requirements for information retrieval in dossier templates – Module 4 4.2.3 Methods of information retrieval

Bibliographic literature search Search in trial registries Selection of relevant studies

4.3.1 Results of information retrieval RCTs of the drug to be assessed Studies for indirect comparisons

Indirect comparisons on the basis of RCTs Non-randomized comparative studies

Further studies Appendix

4-A: Search strategies – bibliographic literature search 4-B: Search strategies – search in trial registries 4-C: List of studies screened as full texts and excluded (with reason for

exclusion) Attachments

RIS files

Informationsbeschaffung in Dossiers 5

Page 6: Review of information retrieval – first experiences in Germany with manufacturer dossiers on new drugs

Content

1) Introduction to the early benefit assessment of new drugs

2) Requirements for information retrieval in the dossier template

3) Review of information retrieval by IQWiG

4) Examples

Informationsbeschaffung in Dossiers 6

Page 7: Review of information retrieval – first experiences in Germany with manufacturer dossiers on new drugs

Informationsbeschaffung in Dossiers 7

Check the search in bibliographic databases

Check the search in trial registries

Evaluate information retrieval

Depending on results of evaluation: (potentially) conduct own search in bibliographic databases and/or trial

registries

Depending on results of evaluation:No further action

Documentation

Process in Information Management Unit:

Page 8: Review of information retrieval – first experiences in Germany with manufacturer dossiers on new drugs

Checking the search in bibliographic databases (formal check)

Methods of information retrievalCheck whether requirements for the search procedure and the presentation of results have been fulfilled as specified in the dossier template

ScreeningWas the procedure for study selection described?Are deviations from the above requirements justified?

Result of the information retrievalCheck consistency of retrieved hits Do the individual sections of the dossier contain consistent information on inclusion and exclusion criteria?

Documentation of the above steps in checklists developed for this purpose.

Informationsbeschaffung in Dossiers 8

Page 9: Review of information retrieval – first experiences in Germany with manufacturer dossiers on new drugs

Checking the search in bibliographic databases (content check)

Is the number of hits plausible?

Checking the search strategy presented in Appendix 4-A Were search filters used and correctly transferred? Syntax acc. to PRESS Checklist

Was the study pool identified via the search strategy? Is the search sensitive enough?

Informationsbeschaffung in Dossiers 9

Sampson M, McGowan J, Lefebvre C, Moher D, Grimshaw J. PRESS: Peer Review of Electronic Search Strategies. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2008. URL: http://www.msmandhiv.org/documents/globaltopics/PRESS.pdf.

Page 10: Review of information retrieval – first experiences in Germany with manufacturer dossiers on new drugs

Informationsbeschaffung in Dossiers 10

Check the search in bibliographic databases

Check the search in trial registries

Evaluate information retrieval

Depending on results of evaluation: (potentially) conduct own search in bibliographic databases and/or trial

registries

Depending on results of evaluation:No further action

Documentation

Process in Information Management Unit:

Page 11: Review of information retrieval – first experiences in Germany with manufacturer dossiers on new drugs

Potential literature searches by IQWiG

1. Search in public trial registries - ClinicalTrials.gov- ICTRP Search Portal and - potentially in industry registries

2. Search in bibliographic databases- Simple Structured Boolean Search (SSBS) - combined with the first 20 Related Citations in PubMed

Informationsbeschaffung in Dossiers 11

Sampson M. Updating searches for systematic reviews. Aberystwyth: University; 2009. URL: http://cadair.aber.ac.uk/dspace/bitstream/2160/3760/1/Sampson%20-%20Updating%20Searches%20for%20Systematic%20Reviews%20-%20PhD.pdf.

Waffenschmidt S, Janzen T, Hausner E, Kaiser T. Assessing the completeness of systematic reviews via the “related articles” function and/or a simple structured Boolean search in PubMed – a pilot study.2011. (Scientific evidence for healthcare quality and patient safety: 19th Cochrane Colloquium; 19.-22.10.2011; Madrid, Spanien).

Page 12: Review of information retrieval – first experiences in Germany with manufacturer dossiers on new drugs

Informationsbeschaffung in Dossiers 12

Check the search in bibliographic databases

Check the search in trial registries

Evaluate information retrieval

Depending on results of evaluation: (potentially) conduct own search in bibliographic databases and/or trial

registries

Depending on results of evaluation:No further action

Documentation

Process in Information Management Unit:

Page 13: Review of information retrieval – first experiences in Germany with manufacturer dossiers on new drugs

Documentation

Informationsbeschaffung in Dossiers 13

Page 14: Review of information retrieval – first experiences in Germany with manufacturer dossiers on new drugs

Content

1) Introduction to the early benefit assessment of new drugs

2) Requirements for information retrieval in the dossier template

3) Review of information retrieval by IQWiG

4) Examples

Informationsbeschaffung in Dossiers 14

Page 15: Review of information retrieval – first experiences in Germany with manufacturer dossiers on new drugs

Examples of shortcomings potentially resulting in a check of the completeness of the study pool by IQWIG

Search strategy errors Lack of sensitivity Lack of plausibility of the number of hits Inconsistencies in search documentation

Informationsbeschaffung in Dossiers 15

Page 16: Review of information retrieval – first experiences in Germany with manufacturer dossiers on new drugs

Syntax errors → Search not sensitive enough

Informationsbeschaffung in Dossiers 16

Page 17: Review of information retrieval – first experiences in Germany with manufacturer dossiers on new drugs

EMBASEInterface: Elsevier

Informationsbeschaffung in Dossiers 17

Ovid Interface results in 64.508

Page 18: Review of information retrieval – first experiences in Germany with manufacturer dossiers on new drugs

Lack of plausibility of the number of hits

Informationsbeschaffung in Dossiers 18

Page 19: Review of information retrieval – first experiences in Germany with manufacturer dossiers on new drugs

Search checked on 08.07.2011: n= 61New citations since 01.05.2011: n=3

Informationsbeschaffung in Dossiers 19

Page 20: Review of information retrieval – first experiences in Germany with manufacturer dossiers on new drugs

Experiences so far

additional relevant studies have only been identified from the list of studies provided by the manufacturer (e.g. study listed but excluded by manufacturer), not by own searches

Challenges in the checking and evaluation of information retrieval: Assessment of the sensitivity of the searches Indirect comparisons and further studies

Informationsbeschaffung in Dossiers 20

Page 21: Review of information retrieval – first experiences in Germany with manufacturer dossiers on new drugs

Conclusions

Our approach to the review of information retrieval in manufacturer dossiers seems to be workable.

Besides checking the search strategies, peer review of information retrieval should cover all aspects of a search.

Ultimately, the in(completeness) can only be verified by doing a focused search yourself .

Informationsbeschaffung in Dossiers 21

Page 22: Review of information retrieval – first experiences in Germany with manufacturer dossiers on new drugs

22

Institute for Quality and Efficiency in Health Care (IQWiG)

Dr. Siw Waffenschmidt

Potential Conflicts of Interest: NONE

Im Mediapark 8 50670 Cologne, Germany Tel: +49-221/3 56 85-0 Fax: +49-221/3 56 85-1 [email protected] www.iqwig.de

22Informationsbeschaffung in Dossiers

Page 23: Review of information retrieval – first experiences in Germany with manufacturer dossiers on new drugs

Search in bibliographic databases

Choice of search techniques is based on the work by Sampson 2009 (“Updating searches for systematic reviews” [PhD])

On the basis of Sampson’s approach, we conducted our own analysis based on systematic reviews of drugs:

Þ Main result:

The combination of the first 20 Related Citations and the SSBS seems to be the most appropriate technique, with high completeness (sensitivity: 97.1%), good reliability (sensitivity range: 80-100%) and an efficient use of resources (precision: 5.0%, NNR: 24).  (manuscript submitted)

Informationsbeschaffung in Dossiers 23

Page 24: Review of information retrieval – first experiences in Germany with manufacturer dossiers on new drugs

Example – IQWiG’s search in PubMed

Informationsbeschaffung in Dossiers 24

Search QueryItems found

#1 Search Sativex*[tiab] or Nabiximol*[tiab] or Cannab*[tiab] or GW*1000*[tiab] or *THC*[tiab] or Marinol*[tiab] or Tetrahydrocannabinol*[tiab] or Nabilon*[tiab]

20478

#2 Search multiple sclerosis 51363

#3 Search #1 and #2 355

#4 Search (Therapy/Narrow[filter]) AND (#3) 33

#5 Search 14615106[pmid] 1

#6 Related Citations for PubMed (Select 14615106) 106

#7 Select 19 document(s) 19

#8 …… ….

Simple Structered Boolean Search

The first 20 Related Citations of the 5 relevant citations included in the dossier

Pubmed: 13.01.2012Total number of hits without duplicates: 70Screening result: no relevant additional studies found